JG
MRSN

Jefferies Group’s Mersana Therapeutics MRSN Stock Holding History

Jefferies Group’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Hold
0
– – – 1508
2020
Q2 		– Hold
0
– – – 1814
2019
Q4 		– Sell
-1,021
Closed -$40K – 2838
2019
Q3 		$40K Buy
1,021
+469
+85% +$34.1K ﹤0.01% 2594
2019
Q2 		$56K Buy
+552
New +$65K ﹤0.01% 2360
2019
Q1 		– Sell
-13,450
Closed -$1.37M – 2530
2018
Q4 		$1.37M Buy
+13,450
New +$2.13M 0.04% 1009

Other funds holding MRSN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return